US Patent 9814721 Use of inhibitors of bruton's tyrosine kinase (BTK)
Patent 9814721 was granted and assigned to Pharmacyclics on November, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9814721 Use of inhibitors of bruton's tyrosine kinase (BTK)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
